← Browse by Condition
Medical Condition
neoplasms
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 1, Phase 3, Phase 2
ClinicalMetric tracks all active clinical trials for neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — neoplasms Clinical Trials
How many clinical trials are currently recruiting for neoplasms?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neoplasms?
neoplasms research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neoplasms clinical trial?
Eligibility criteria for neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05066139
Recruiting
Enrollment
144 pts
Location
France
Sponsor
Centre Paul Strauss
NCT04192344 Phase 1
Recruiting
Enrollment
276 pts
Location
United States, China
Sponsor
Abbisko Therapeutics Co, Ltd
NCT06496971 Phase 3
Recruiting
Enrollment
32 pts
Location
Taiwan
Sponsor
NaviFUS Corporation
NCT04075305
Recruiting
Enrollment
8,000 pts
Location
United States, Austr...
Sponsor
UMC Utrecht
NCT03911388 Phase 1
Recruiting
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05534386
Recruiting
Enrollment
486 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
NCT06177925 Phase 2
Recruiting
Enrollment
62 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
NCT07215169
Recruiting
Enrollment
40 pts
Location
Sweden
Sponsor
Lund University
NCT05733156
Recruiting
Enrollment
52 pts
Location
South Korea
Sponsor
Soonchunhyang University Hospi...
NCT06717581
Recruiting
Enrollment
50 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
NCT06505057
Recruiting
Enrollment
100 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology